Delusions and hallucinations in dementia with Lewy bodies: Worsening with memantine

Three patients with probable dementia with Lewy bodies (DLB) experienced worsening delusions and visual hallucinations as a result of memantine therapy. Significant resolution occurred once treatment was discontinued. Caution is required when prescribing memantine to patients with possible DLB.

[1]  Pierre N Tariot,et al.  Memantine treatment in patients with moderate to severe Alzheimer disease already receiving donepezil: a randomized controlled trial. , 2004, JAMA.

[2]  W. van Tilburg,et al.  Visual Hallucinations and Delirium During Treatment with Amantadine (Symmetrel) , 1975, Journal of the American Geriatrics Society.

[3]  S. Lipton,et al.  Excitatory amino acids as a final common pathway for neurologic disorders. , 1994, The New England journal of medicine.

[4]  J. Kornhuber,et al.  Memantine in moderate-to-severe Alzheimer's disease. , 2003, The New England journal of medicine.

[5]  M. Merello,et al.  Effect of memantine (NMDA antagonist) on Parkinson's disease: a double-blind crossover randomized study. , 1999, Clinical neuropharmacology.

[6]  J. Kornhuber,et al.  Pharmacotoxic psychosis after memantine in Parkinson's disease , 1991, The Lancet.

[7]  Alan J. Thomas,et al.  What happens when donepezil is suddenly withdrawn? An open label trial in dementia with Lewy bodies and Parkinson's disease with dementia , 2003, International journal of geriatric psychiatry.

[8]  M. Weller,et al.  Psychotogenicity and N-methyl-D-aspartate receptor antagonism: Implications for neuroprotective pharmacotherapy , 1997, Biological Psychiatry.

[9]  E. Kosno-Kruszewska,et al.  Lewy body variant of Alzheimer's disease and Alzheimer's disease: a comparative immunohistochemical study. , 2001, Folia neuropathologica.

[10]  D. Soutif,et al.  Sexual disturbances during omeprazole therapy , 1991, The Lancet.